SBFM - sunshinebiopharma.com Market Capitalization

Graphic logo of Sunshine Biopharma, Inc. (SBFM)

The stock price trend for Sunshine Biopharma (SBFM) on the GURU.Markets platform reflects the dynamics of an asset whose revenue is based on bringing breast cancer and antiviral drugs to market. The current indicator is 0.00. Sunshine Biopharma (SBFM) combines the production of generic drugs with scientific research to combat resistant tumors. Meanwhile, amid unstable revenues and a need for investment, management is adjusting its medical plans.

SBFM Sunshine Biopharma Inc.: Market Valuation in the range 07/04/2022 - 11/12/2026
Product sample of Sunshine Biopharma

The market capitalization of Sunshine Biopharma (SBFM) is calculated as the product of the current share price and the total number of outstanding securities. This aggregator measures the total value of the business, reflecting market confidence in the issuer's assets. For Sunshine Biopharma, this metric depends directly on the efficiency of climate regulation compliance during the delivery of oncology drugs. Stable logistics chains minimize the risks of medication degradation. By analyzing the company's public capitalization chart, an investor can assess the fundamental stability of the business.

Competitors of Sunshine Biopharma (SBFM)

Market Capitalization ONC (BeiGene)|Halozyme Therapeutics, Inc. - Market Value|RevMed - Market Capitalization|Market Valuation AAPG|CG Oncology, Inc. (CGON) - Market Value|Market Valuation urogen.com|BCAX (Bicara Therapeutics) - Market Capitalization|Market Valuation Personalis Inc (PSNL)|Market Capitalization ERAS|Market Capitalization Delcath Corp (DCTH)|Market Value Y-mAbs Therapeutics YMAB|AURA: Market Capitalization|Candel - Market Capitalization|Accuray Inc (ARAY) - Market Valuation|SLS: Market Capitalization|Market Value Actuate Therapeutics Inc (ACTU)|Market Value Citius Oncology, Inc.|HURA: Market Value|Market Valuation TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Market Value|Market Capitalization WHWK (Aadi Bioscience)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|cel-sci.com (CVM) - Market Value|OS Therapies Inc. - Market Value|RADX (Radiopharm Theranostics) - Market Capitalization|Market Value Artiva ARTV|Market Value Adlai Nortye Ltd. (ANL)|Market Capitalization verupharma.com|Tempest Therapeutics, Inc. - Market Valuation|Market Capitalization Xilio Therapeutics Inc XLO|RENB - Market Value|MURA (Mural Oncology plc) - Market Capitalization|kairospharma.com (KAPA) - Market Value|OKUR - Market Capitalization|GDTC (CytoMed Therapeutics Ltd) - Market Capitalization|CRIS: Market Value|Market Capitalization APLM|Market Capitalization Tharimmune Corporation|Market Value Advanced Biomed ADVB|GNPX: Market Capitalization|Calidi Bio - Market Capitalization|Market Value Xenetic Biosciences|SLRX (Salarius) - Market Valuation|Kitov Pharma - Market Value|AONC (American Oncology Network Inc) - Market Capitalization|Market Value BGNE|Market Capitalization CKPT|Market Capitalization Elevation Oncology Inc.|Market Value iCAD ICAD|Ikena Oncology Inc. (IKNA) - Market Value|NTBL - Market Value|Market Valuation VIRX|MOR: Market Capitalization|NAYA Biosciences Inc - Market Value|AAPGV (Ascentage Pharma Group Ltd) - Market Capitalization